On the occasion of World Cancer Day 2024; focus on hypertension and anti-cancer agents

被引:0
|
作者
Tajdini, Parisa [1 ,2 ]
Foroutan, Majid [3 ,4 ]
机构
[1] Semnan Univ Med Sci, Sch Med, Dept Pediat, Semnan, Iran
[2] Semnan Univ Med Sci, Amir Al Momenin Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
[3] Semnan Univ Med Sci, Dept Internal Med, Semnan, Iran
[4] Semnan Univ Med Sci, Kowsar Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
来源
JOURNAL OF RENAL INJURY PREVENTION | 2024年 / 13卷 / 01期
关键词
Oncohypertension; High blood pressure; Cancer; Blood pressure; Pathophysiology; Diagnosis; ANTIHYPERTENSIVE TREATMENT; PARANEOPLASTIC SYNDROMES; ONCO-HYPERTENSION; GROWTH-FACTOR; DIAGNOSIS; TARGET; RISK; PHEOCHROMOCYTOMA; CARDIOLOGY; SYSTEM;
D O I
10.34172/jrip.2024.32259
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non -pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes
引用
收藏
页数:6
相关论文
共 50 条
  • [31] SYNTHESIS OF POTENTIAL ANTI-CANCER AGENTS
    SINGH, NN
    SINGH, B
    SINGH, GP
    SINGH, PN
    PATNA, PU
    HETEROCYCLES, 1984, 21 : 440 - 440
  • [32] Nephrotoxicity of recent anti-cancer agents
    Lameire, Norbert
    CLINICAL KIDNEY JOURNAL, 2014, 7 (01): : 11 - 22
  • [33] Rebeccamycin analogues as anti-cancer agents
    Prudhomme, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (02) : 123 - 140
  • [34] Anti-Cancer Agents in Medicinal Chemistry
    Das, Biswajit
    Kundu, Chanakya N.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (04) : 416 - 427
  • [35] POTENTIAL ANTI-CANCER AGENTS - ANTI-CANCER INDOLE ALKALOIDS OF ERVATAMIA-HEYNEANA
    GUNASEKERA, SP
    CORDELL, GA
    FARNSWORTH, NR
    PHYTOCHEMISTRY, 1980, 19 (06) : 1213 - 1218
  • [36] Plants as a source of anti-cancer agents
    Cragg, GM
    Newman, DJ
    JOURNAL OF ETHNOPHARMACOLOGY, 2005, 100 (1-2) : 72 - 79
  • [37] Proteasome inhibitors as anti-cancer agents
    Murray, RZ
    Norbury, C
    ANTI-CANCER DRUGS, 2000, 11 (06) : 407 - 417
  • [38] Mitochondrially targeted anti-cancer agents
    Biasutto, Lucia
    Dong, Lan-Feng
    Zoratti, Mario
    Neuzil, Jiri
    MITOCHONDRION, 2010, 10 (06) : 670 - 681
  • [39] RNA molecules as anti-cancer agents
    Friedrich, I
    Shir, A
    Klein, S
    Levitzki, A
    SEMINARS IN CANCER BIOLOGY, 2004, 14 (04) : 223 - 230
  • [40] Hypertension after anti-cancer therapy
    Leitch, Victoria
    Ngo, Doan
    Sverdlov, Aaron
    HEART LUNG AND CIRCULATION, 2023, 32 (11): : 1407 - 1407